kabutan

Welby Inc.(4438) Summary

4438
TSE Growth
Welby Inc.
413
JPY
+38
(+10.13%)
Mar 13, 3:30 pm JST
2.59
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
400.2
Mar 13, 11:12 pm JST
Summary Chart Historical News Financial Result
PER
PBR
15.5
Yield
ー%
Margin Trading Ratio
Stock Price
Mar 13, 2026
Opening Mar 13, 9:03 am
361 JPY 2.26 USD
Previous Close Mar 12
375 JPY 2.35 USD
High Mar 13, 10:38 am
439 JPY 2.75 USD
Low Mar 13, 10:00 am
344 JPY 2.16 USD
Volume
1,218,700
Trading Value
0.50B JPY 3.14M USD
VWAP
410.92 JPY 2.58 USD
Minimum Trading Value
41,300 JPY 259 USD
Market Cap
3.42B JPY 0.02B USD
Number of Trades
3,016
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Mid
1-Year Average
218
1-Year High Mar 4, 2026
6,261
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 0 302,400
Feb 27, 2026 2,800 194,800 69.57
Feb 20, 2026 0 219,100
Feb 13, 2026 0 228,000
Feb 6, 2026 0 239,200
Company Profile
Welby Inc. provides personal health management platforms for lifestyle-related diseases and other conditions, primarily serving pharmaceutical companies, medical institutions, and healthcare-related organizations.
Sector
Information & Communication
Welby Inc. develops and operates PHR (Personal Health Record) platform services to support self-management for patients with lifestyle-related diseases and various other conditions. The company primarily works on commission from pharmaceutical companies to develop and manage platforms that promote proper use of new drugs and raise disease awareness upon market launch. Additionally, through its proprietary service "Welby MyKarte," the company supports self-management for patients with lifestyle-related diseases. These services facilitate information sharing between patients and healthcare professionals, contributing to treatment continuity and promoting self-health management. Revenue primarily consists of service development fees and usage fees from pharmaceutical companies, as well as charges to health insurance associations and corporations. With patient consent, accumulated data is also made available for sharing with healthcare professionals and for academic purposes.